Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0000875320-25-000247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-12-05 | 2025-12-03 | VRTX | WAGNER CHARLES F JR | EVP, CO, FO | S - Sale | $456.00 | -14.0K | 37.7K | -27% | -$6.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-03 | S | D | 7,000 | $451.00 | 44,725 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-03 | S | D | 7,000 | $461.00 | 37,725 | D | — | — |